# OnCo record gadobutrol (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/gadobutrol/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "gadobutrol" ;
  schema:name "Gadobutrol"@en ;
  schema:alternateName "gadobutrol"@en, "Gadavist"@en, "Pixxoscan"@en, "Gadavist" ;
  schema:description "A widely used MRI dye given into a vein. Its American licence includes brain and spine scans and breast MRI to see how far a breast cancer extends."@en ;
  schema:url <https://onco.cc/drugs/gadobutrol/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201277>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bd28560f-de4d-4140-874e-31df823f4dbb>, <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215957>, <https://atcddd.fhi.no/atc_ddd_index/?code=V08CA&showdescription=no> ;
  onco:status "approved" ;
  onco:tag "contrast-agents-gaps-2026-11", "diagnostic" ;
  onco:modality "Gadolinium-based contrast agent for MRI (intravenous)" ;
  onco:approval "US 2011: MRI of the central nervous system; breast MRI to assess the presence and extent of malignant breast disease; MR angiography; cardiac MRI" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/secondary-brain-tumours/> ;
  onco:technologies <https://onco.cc/technologies/gadolinium-based-contrast-agents/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/breast-mri-coils-abbreviated-mri/> ;
  onco:companies <https://onco.cc/companies/bayer/>, <https://onco.cc/companies/ge-healthcare/> .